<?xml version="1.0" encoding="UTF-8"?>
<p>The process developed has been recognised by Cathy Harrison, Chief Pharmaceutical Officer at the Department of Health, commenting 
 <italic>‘I very much welcome the development of the supply and demand model for critical care medicines and I support its use for managing and monitoring other groups of essential medicines and healthcare supplies at risk of potential shortages. The model provided essential information and assurance during the response to COVID-19 and I commend all those involved in its development’</italic>.
</p>
